Learning Center: Thyroid Cancer Outcomes by Treatment
Most thyroid cancers have an excellent outlook, and several treatment choices lead to very similar long-term survival. These pages redraw the results of major studies so readers can see how people with the same type and extent of thyroid cancer did after different treatments, including how often the cancer came back and what side effects followed.
How to use these pages
Last reviewed: November 8, 2026
Pick the type of thyroid cancer, how far it has spread, and the treatment question of interest. Each choice leads to a page with redrawn survival curves, a plain-language summary, and a table of other outcomes such as complications and quality of life.
Choose one answer in each row to see the matching page.
Why these pages group cancers by risk, not by stage
For papillary and follicular thyroid cancer, the official cancer stage depends heavily on age. Everyone under 55 without spread to distant organs is "stage I," whether the tumor is 1 cm or 6 cm and whether or not lymph nodes are involved. That makes stage a poor way to compare treatments.
Thyroid specialists instead use risk groups from the American Thyroid Association. These pages use plain-language versions:
Small and inside the thyroid (low risk): a tumor up to 4 cm that has not grown outside the thyroid and has no lymph node spread seen before or during surgery.
Spread to nearby lymph nodes or just outside the thyroid (intermediate risk): small amounts of growth into tissue around the thyroid, spread to lymph nodes in the neck, or a more aggressive microscopic type.
Spread to distant sites (high risk): spread to the lungs, bones or other organs, obvious growth into neck structures, or tumor that could not be fully removed.
The Thyroid Tumors page explains these cancer types in more detail.
How to read a survival curve
A survival curve (also called a Kaplan-Meier curve) starts at 100% on the day of treatment. Each step down shows people who had the event being measured. A flat line near the top means the event was rare.
These pages show three different measures. It matters which one is being shown:
| Measure | What it counts | Why it matters |
|---|---|---|
| Overall survival | Deaths from any cause | Mostly reflects age and other health problems in thyroid cancer, because few people die of the cancer |
| Disease-specific survival | Deaths from thyroid cancer only | The best measure of whether a treatment saves lives |
| Recurrence-free survival | The cancer coming back, or not going away | Usually the most informative measure for thyroid cancer, because survival is so high |
A caution about the studies
Only a few of these comparisons come from randomized trials, where chance decides who gets which treatment. Most come from records of past patients. In those studies, the people offered more surgery or radioactive iodine often had larger tumors, or were younger and healthier, so differences in the curves may reflect who received a treatment rather than what the treatment did. Each page says which kind of study it shows.
Related pages
Learning Center Main Index:
Throat:
swallowing, tonsils and adenoids, obstructive sleep apnea, voice, oral lesions and mucositis
Aesthetics:
skin regimen, injectables {neuromodulators (e.g., Botox), hyaluronic acid fillers (e.g., Juvederm), and others}, rhinoplasty, chin, facelift, neck lift, and brow lift, blepharoplasty (eyelid surgery), skin resurfacing, scar treatment
Tumors (benign and malignant/cancerous):
general tumor information, thyroid, thyroid cancer outcomes by treatment, parathyroid, skin, neck, lymphatics, oropharynx, larynx (voice box), salivary gland, nose and sinus, inverted papilloma, oral cavity (mouth and lips), nasopharynx, hypopharynx, radiation therapy, chemotherapy and immunotherapy, gastric feeding tube, central line
Nose and Sinus:
rhinoplasty (functional and cosmetic), sinusitis, breathing
Ear:
This page